Carrier Screening Market Size by Type, Medical Condition, Technology, End User, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2034
Overview
The Carrier Screening Market size was valued at USD 3.23 Billion in 2025 and the total Carrier Screening revenue is expected to grow at a CAGR of 14.6% from 2026 to 2034, reaching nearly USD 11.01 Billion.
Carrier Screening Market Overview
Carrier screening is a type of genetic test in the medical field, which tells whether a person is carrying a gene for certain genetic disorders. The test is carried out mostly before the pregnancy to know the chances of having a genetic disorder in the child. As they said, “Precaution is better than cure” so, the growing need to detect the disease early is the major factor that is expected to drive the Carrier Screening Market. The growing trend of using Next-generation Sequencing Technology is a lucrative opportunity for Carrier Screening Key Players to invest in Carrier Screening Market.
The cost of a Carrier Screening Test varies as per the complexity of the test, which might hamper the growth of the Carrier Screening Market. Recently, MedGenome, a genetic diagnostic company is adopting inorganic growth to grow their business in developing markets by partnering with other Carrier Screening Companies and advancing their Carrier Screening Solutions using artificial intelligence (AI) and machine learning (ML). The report has included all the important segments in the Carrier Screening Market and helps the client to understand the market.
Carrier Screening Market Snapshot
To know about the Research Methodology :- Request Free Sample Report
Carrier Screening Market Research Methodology
The report provides detailed data regarding the latest innovations and mergers and acquisitions happening in the market. The report involves the details of the Carrier Screening Key Players’ partnerships with local players in major geographic regions such as North America, Asia Pacific, Europe, Middle East and Africa and South America. The report analyses the market through Carrier Screening Key Companies’ market share and their gross income, recent developments and business strategies, which is expected to help Carrier Screening New Market Entrants.
The bottom-up approach was used to estimate the size of the Market by value and volume. Primary and secondary research methods were used to collect data. The data from interviews with market leaders and opinions from business owners and research analysts. Secondary data were gathered from annual reports of organizations and paid databases. Collected data was later analyzed by SWOT analysis, PORTER’s five force model, which includes drivers, restraints, opportunities and the competitive landscape in the Carrier Screening Market.
Carrier Screening Market Dynamics
Drivers:
Increased rate of genetic illness and disorders drives the demand for the Market. Also the growing consciousness regarding the benefits of early diagnosis of cystic fibrosis, Tay - Sachs disease and sickle cell anemia such genetic disorders. These factors are expected to create a lucrative opportunity for Carrier Screening Key Companies to invest in the Market.
The market has been growing due to the inorganic growth of the key players in the Market. Many companies are evaluating inorganic growth to increase their market share through mergers and collaborations and partnerships. The market growth is supported by the increased investment by key players in developing and poor resource countries to increase the efficiency of diagnosis in those regions and hold the largest market share.
1. The Carrier screening tests are cost-effective and provide accurate results as compared to traditional screening.
2. Growing concerns about the health of a future generation also driving the Carrier Screening Market.
3. Continuous improvements by key companies in the development of Carrier Screening Solutions.
4. Trends such as expanding carrier screening and next-generation sequencing is expected to drive the Carrier Screening Market.
Restraining Factors in Carrier Screening Market
Strict regulations in the approval of carrier screening tests and ethical concerns about their screening and confidentiality are expected to hinder the growth of the Carrier Screening Market. The report includes all aspects of the market and provides solutions. Lack of awareness about the screening tests and the high cost associated with carrier screening tests for complex DNA sequencing are limiting the growth of the market.
Carrier Screening Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 16 May 2025 | BillionToOne, Inc. | The molecular diagnostics firm launched its expanded 14-gene panel for the UNITY Fetal Risk Screen, upgrading its previous 5-gene prenatal carrier screening offering. | The upgraded single maternal blood test enables earlier risk assessment for up to 14 recessive and X-linked conditions at 9 weeks gestation without needing a paternal sample. |
| 25 September 2025 | Pacific Biosciences (PacBio) | The genomics developer commercialized its expanded PureTarget portfolio, introducing specialized HiFi long-read sequencing kits optimized for high-throughput carrier screening. | The long-read kits allow laboratories to consolidate multiple fragmented workflows into a single test that fully resolves technically challenging tier 3 genes like SMN1 and FMR1. |
| 04 March 2026 | Devyser Diagnostics AB | The diagnostic company officially commercialized Devyser Thalassemia v2, a next-generation sequencing assay for analyzing genetic hemoglobinopathies. | This launch delivers the first-ever IVDR-approved NGS assay for genetic analysis of thalassemia and sickle cell disease available across the European market. |
| 14 April 2026 | Maven Clinic | The virtual health platform rolled out an expansion to its Fertility & Family Building program, incorporating earlier genetic carrier screening directly into its care workflows. | Integrating carrier panels earlier in the reproductive cycle helps individuals identify potential genetic barriers and transition to specialized care tracks faster. |
Carrier Screening Market Regional Insights
North America is expected to grow significantly at the highest CAGR of 11.9 percent to hold the largest share of the Market during the forecast period (2026-2034). Recently, a study published in ‘Jama Network Open’ around 41 percent of infant deaths in the United States is related to genetic disease. The practical and accurate diagnosis of the genetic disorder with the help of expanded screening techniques and advanced solutions is the need of an hour in the United States. The federal government is promoting the Carrier Scanning Key Companies in the region to develop more advanced Carrier Screening Solutions. These factors have been driving the growth of the North America Carrier Screening Market.
A study published by BMC Medical Genetics on November 2, 2020, states that 26 percent of the North Indian population is found as a carrier of more than one genetic disorder. This is expected to increase the growth of the Carrier Screening Market. The increased expenditure of the developing economies on healthcare infrastructure has been driving the Asia Pacific market growth.
Carrier Screening Market Competitive Landscape
The market is highly fragmented and the report provides a detailed analysis of the Market Key Competitors based on their recent developments, business strategies and their solution penetration in the Carrier Screening Market. Med Genome is one of the leading company decided to grow their business by evaluating inorganic growth. On Feb 28, 2023, Fulgent Genetics launched the new Beacon787 expanded carrier screening panel, which is expected to provide an accurate option for carrier screening. Myriad Genetics and Simon Med Imaging announced their collaboration to advance the diagnosis with a new genetic screening risk management program. The report involves the competitive landscape of all the Market Key Competitors, which is expected to help new market entrants to develop their strategies accordingly.
Carrier Screening Market Segment Analysis:
The expanded Market segment dominated the market in 2025 and is expected to grow significantly during the forecast period. Expanded carrier screening looks for multiple carrier mutations that are possible practically and doesn’t make assumptions based on ethnicity or family history. This basic difference is driving the end users to completely rely on expanded carrier screening. Expanded carrier screening provides an accurate result in the diagnosis of genetic disorders. Expanded carrier screening uses Next-generation sequencing (NGS) and high-density microarrays technology platforms in the diagnosis of genetic disorders. These factors have been driving the growth of the expanded carrier screening segment in the Carrier Screening Market.
Based on end users, hospitals and clinics i.e. healthcare segment is expected to hold the largest revenue share in the Market. As the main use of carrier screening is in the diagnosis of gene disorders, cancer patients and others.
Carrier Screening Market Scope: Inquire before buying
| Carrier Screening Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | USD 3.23 Bn. |
| Forecast Period 2026 to 2034 CAGR: | 14.6 % | Market Size in 2034: | USD 11.01 Bn. |
| Segments Covered: | by Type | 1. Expanded Carrier Screening 1. Customized Panel Testing 2. Predesigned Panel Testing 2. Targeted Disease Carrier Screening |
|
| by Medical Condition | 1. Pulmonary Conditions 2. Hematological Conditions 3. Neurological Conditions 4. Other Conditions |
||
| by Technology | 1. DNA Sequencing 2. Polymerase Chain Reaction 3. Microarrays 4. Others |
||
| by End User | 1. Hospitals and clinics 2. Reference Laboratories 3. Physician Offices 4. Others |
||
Carrier Screening Market, by Region:
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Carrier Screening Market, Key Players are:
1. Carrier Screening & Reproductive Genetic Testing Companies
These companies provide carrier screening tests that assess inherited genetic disorders for prospective parents and reproductive health applications.
North America
1. Natera, Inc. – United States
2. Myriad Genetics, Inc. – United States
3. Labcorp Holdings Inc. – United States
4. Invitae Corporation – United States
Europe
1. Eurofins Scientific SE – Luxembourg
2. CENTOGENE N.V. – Germany
Asia Pacific
1. BGI Genomics Co., Ltd. – China
2. MedGenome Labs Ltd. – India
2. Genomic Sequencing & Genetic Analysis Platform Providers
These companies provide sequencing technologies and genomic analysis platforms used in carrier screening workflows.
North America
1. Illumina, Inc. – United States
2. Thermo Fisher Scientific Inc. – United States
3. PacBio – United States
Europe
1. Oxford Nanopore Technologies plc – United Kingdom
2. QIAGEN N.V. – Netherlands
Asia Pacific
1. BGI Genomics Co., Ltd. – China
2. MGI Tech Co., Ltd. – China
3. Molecular Diagnostics & Clinical Genetic Testing Companies
These companies offer molecular diagnostic services and genetic testing solutions supporting carrier screening and hereditary disease detection.
North America
1. Quest Diagnostics Incorporated – United States
2. Labcorp Holdings Inc. – United States
3. Myriad Genetics, Inc. – United States
Europe
1. Eurofins Scientific SE – Luxembourg
2. QIAGEN N.V. – Netherlands
Asia Pacific
1. MedGenome Labs Ltd. – India
2. CENTOGENE Middle East & Asia Operations – United Arab Emirates/Asia Pacific
4. Prenatal, Reproductive Health & Fertility Genetics Companies
These companies focus on reproductive genetics, fertility testing, prenatal screening, and family planning solutions.
North America
1. Natera, Inc. – United States
2. CooperSurgical, Inc. – United States
Europe
1. Vitrolife AB – Sweden
Asia Pacific
1. Genea Limited – Australia
2. MedGenome Labs Ltd. – India
5. Rare Disease & Hereditary Disorder Testing Companies
These companies specialize in genetic testing for rare inherited diseases and hereditary disorders that are commonly included in carrier screening panels.
North America
1. Invitae Corporation – United States
2. Myriad Genetics, Inc. – United States
Europe
1. CENTOGENE N.V. – Germany
Asia Pacific
1. BGI Genomics Co., Ltd. – China
2. MedGenome Labs Ltd. – India
Frequently Asked Questions:
1] What is the growth rate of the Market?
Ans. The Market is growing at a CAGR of 14.6 % during the forecast period.
2] Which region is expected to dominate the Market?
Ans. North America is expected to dominate the Market during the forecast period from 2026 to 2034.
3] What was the Global Carrier Screening Market size in 2025?
Ans: The Global Carrier Screening Market size was USD 3.23 Billion in 2025.
4] Who are the top players in the Market?
Ans. The major key players in the Market are Azenta, Ambry Genetics, Pathway Genomics and BGI Genomics.
5] Which factors contributed to the growth of the Market in 2025?
Ans. The Market is expected to grow due to increased rate of gene disorders.